Supplementary data
Derivation of tumor size metrics using the simplified tumor growth inhibition model: A simplified version of the previously developed semi-mechanistic exposuredriven tumor growth inhibition (TGI) model (2) was used to fit tumor size data and estimate tumor size metrics that will be used capture treatment effect and to predict survival. The TGI model is described by the differential equation below:
dTS KL TS t KD t Exposure t TS t dt KD t KD e TS 0
where TS is the tumor size; KL and KD are the tumor growth rate and tumor growth inhibition rate, respectively;  is the rate constant that accounts for a decrease in tumor growth inhibition rate (KD) over time; TS 0 is the observed tumor size as baseline; and Exposure is drug exposure (e.g. dose, AUC).
As we are not interested in exposure inferences, the TGI model can be simplified by assuming constant exposure over time. The differential equation can be solved as follows:
For i=1…N individuals and j=1…to M observations
Note that in this case KDE is an exposure-adjusted tumor growth inhibition rate and λ accounts for both resistance appearance and decrease in efficacy due to dose reductions if any.
Lognormal distribution is assumed for inter-individual variability on each of the parameters. Additive error (e) is assumed for residual variability and e follows a normal distribution with mean 0 and variance σ 2 .
The model was implemented in NONMEM version 7. Estimation of model parameters was performed using the first order conditional estimation method (FOCE) with interaction (17). Individual (posthoc) estimates were obtained using empirical bayesian estimation (17), uncertainty in individual estimates was not considered.
Individual estimates of KL, KDE and λ allowed the computation of the theoretical time to growth (TTG). Growth occurs when: 
log KDE log KL TTG TTG is a metrics that depends on all model parameters and is expressed in time unit.
Estimation of tumor growth rate using the empirical tumor size model
The empirical tumor size model (13) describes TS(t)/Baseline with a biexponential function (shrinkage rate and growth rate)
Where G is the growth rate constant, and D the decay rate constant Log(G) (the growth rate) is correlated with survival in prostate cancer (13).
We have improved this model implementation by using non-linear mixed effect modeling and in estimating the baseline:
The model was implemented in NONMEM version 7. Estimation of model parameters was performed using the first order conditional estimation method (FOCE) with interaction (17). Individual (posthoc) estimates of G were obtained using empirical bayesian estimation (17), uncertainty in individual estimates was not considered.
Supplementary Figure 1: Tumor size data in each of the study arms
Figure represents spagetti plots of tumor size data in each evaluable individual (light grey) with 10% of randomly choosen patients to enlighten typical profiles (blue) 
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